| The Schall Law Firm Invites Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Related Infractions | 11/04 11:00 | accesswire.com |
| Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm | 11/03 11:00 | accesswire.com |
| The Schall Law Firm Urges Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations | 11/02 11:00 | accesswire.com |
| Syros Pharmaceuticals, Inc (SYRS) Q3 2024 Earnings Call Transcript | 10/31 14:21 | seekingalpha.com |
| Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update | 10/31 07:30 | businesswire.com |
| Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Affected Shareholders Are Encouraged To Contact The Schall Law Firm | 10/27 11:00 | accesswire.com |
| The Schall Law Firm Urges Investor Participation In An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations | 10/26 11:00 | accesswire.com |
| Syros to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024 | 10/24 07:08 | businesswire.com |
| Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Impacted Shareholders Are Encouraged To Contact The Schall Law Firm | 10/21 11:00 | accesswire.com |